You've hit one of our legacy pages, and this content may be out of date. Visit our Market Landscapes page to see the latest content.
You will be redirected to the Landscapes page in 10 seconds.
These kits use advanced quantitative PCR (qPCR) technology with high sensitivity and specificity to reliably identify and quantify bacterial DNA residues. This is essential to ensure the safety and efficacy of biologics, vaccines and other pharmaceuticals. In addition, each kit comes with pre-optimized reagents and comprehensive instructions for seamless integration into existing laboratory protocols. The rapid and accurate results provided by these kits help manufacturers meet stringent regulatory standards and maintain strict quality control throughout the manufacturing process.
Bacterial DNA residue assay kits (qPCR) are essential for maintaining the highest levels of product integrity and compliance in the biopharmaceutical industry. As an expert in bioprocess impurity analysis, Creative Diagnostics offers a range of Bacterial DNA Residue (qPCR) assay kits for the detection of trace levels of bacterial DNA contamination in biopharmaceutical products. By effectively monitoring for bacterial DNA contamination, these assay kits prevent potential adverse effects and ensure that the final product is safe for human use.
Location
New York Shirley, New York 11967
Number of Employees
1-10